Tara A Altepeter MD
Associate Director for Therapeutic Review
Join to View Full Profile
10903 New Hampshire AveSilver Spring, MD 20993
Phone+1 240-402-2458
Dr. Altepeter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Altepeter leads a team of physicians and scientists in the Office of New Drugs, at FDA's Center for Drug Evaluation and Research (CDER) in the Division of Gastroenterology. Her interests include Inflammatory Bowel Disease, functional GI disorders, and pediatric drug development.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonFellowship, Pediatric Gastroenterology, 2012 - 2015
Advocate Health Care/Advocate Children’s Hospital (Oak Lawn)Residency, Pediatrics, 2008 - 2011
University of Illinois College of MedicineClass of 2008
Certifications & Licensure
DC State Medical License 2015 - 2027
MD State Medical License 2024 - 2026
DE State Medical License 2012 - 2016
IL State Medical License 2008 - 2014
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
Publications & Presentations
PubMed
- Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.Sophie Shubow, Michele Gunsior, Amy Rosenberg, Yow-Ming Wang, Tara Altepeter
The AAPS Journal. 2025-03-14 - 9 citationsImmune-mediated colitis associated with ocrelizumab: A new safety risk.Tiffany Kim, Allen Brinker, David Croteau, Paul R Lee, Laura E Baldassari
Multiple Sclerosis. 2023-09-01 - 14 citationsPaediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents.Nicholas M Croft, Lissy de Ridder, Anne M Griffiths, Jeffrey S Hyams, Frank M Ruemmele
Journal of Crohn's & Colitis. 2023-03-18
Press Mentions
New Bowel Disorder Treatments Needed, FDA SaysApril 17th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
